The correlation of plasma and urine endothelin-1 with the severity of nephropathy in Chinese patients with Type 2 diabetes

References

• Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–15
   PubMed Web of Science ®Google Scholar
• Takahashi K, Ghatei MA, Lam HC, Ohalloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33: 306–10
   PubMed Web of Science ®Google Scholar
• Kawarnura M, Ohgawara H, Naruse M, Suzuki N, Iwasaki N, Naruse K, et al. Increased plasma ndothelin in NIDDM patients with retinopathy. Diabetes Care 1992; 15: 1396–7
   PubMedGoogle Scholar
• Collier A, Leach JP, McLellan A, Jardine A, Morton JJ, Small M. Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 1992; 15: 1038–40
   PubMed Web of Science ®Google Scholar
• Haak T, Jungmann E, Felber A, Hillmann U, Usadkl KH. Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 1992; 5: 161–6
   PubMed Web of Science ®Google Scholar
• Kohno M, Yasimaro K, Murakawa K-I, Yokokawa K, Horio T, Fukui T, et al. Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88: 614–8
   PubMed Web of Science ®Google Scholar
• Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, et al. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15: 493–6
   PubMed Web of Science ®Google Scholar
• Naruse K, Naruse M, Watanage Y, Yoshihara I, Ohsumi K, Horiuchi J, et al. Molecular form of immunoreactive endothelin in plasma and urine of normal subjects and patients with various disease states. J Cardiovasc Pharm 1991; 17: S506–8, Suppl 7
   PubMed Web of Science ®Google Scholar
• Stockenhuber F, Gottsauner-Wolf M, Marosi L, Liebisch B, Kun RW, Balcke P. Plasma levels of endotheh in chronic renal failure and after renal transplantation: impact on hypertension and cyclosporin A-associated nephrotoxicity. Clin Sci 1992; 82: 255–8
   PubMed Web of Science ®Google Scholar
• Predel HG, Meyer-Lehnert H, Backer A, Stelkens H, Kramer HJ. Plasma concentrations of endothelin in patients with abnormal vascular reactivity. Life Sci 1990; 47: 1837–43
   PubMed Web of Science ®Google Scholar
• Bertello P, Veglio F, Pinna G, Gurioli L, Molino P, Alban S, et al. Plasma endotheliu in NIDDM patients with and without complications. Diabetes Care 1994; 17: 574–7
   PubMed Web of Science ®Google Scholar
• Sakamoto H, Sasaki S, Hirata Y, Imai T, Ando K, Ida T, et al. Production of endothelin-1 by rat cultured mesangial cells. Biochem Biophys Res Commun 1990; 169: 462–8
   PubMed Web of Science ®Google Scholar
• Marsden PA, Dorfman DM, Collins T, Brenner BM, Orkin SH, Ballermann BJ. Regulated expression of endothelin-1 in glomerular capillary endothelial cells. Am J Physiol 1991; 261: F117–25
   PubMed Web of Science ®Google Scholar
• Shichiri M, Hirata Y, Emori T, Ohta K, Nakajima T, Sato K, et al. Secretion of endothelin and related peptides from renal epithelial cell lines. FEBS Lett 1989; 253: 203–6
   PubMed Web of Science ®Google Scholar
• King AJ, Brenner BM, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989; 256: F1051–8
   PubMed Web of Science ®Google Scholar
• Simonson MS, Wann S, Mene P, Dubyac GR, Kester M, Nakazato Y, et al. Endothelin stimulates phospholipase C, Na+/H+exchangec-fosexpression, and mitogenesis in rat mesaagial cells. J Clin Invest 1989; 83: 708–12
   PubMed Web of Science ®Google Scholar
• Ishimura E, Shouji S, Nishizawa Y, Morii H, Kashgarian M. Regulation of mRNA expression for extracellular matrix (ECM) by cultured rat mesangial cells (MCS) [Abstract]. J Am Soc Nephrol 1991; 2: 546
   Google Scholar
• Berbinschi A, Keteislegers JM. Endothelin in urine. Lancet 1989; ii: 46–9
   Google Scholar
• Abassi ZA, Tate J, Golomb E, Keiser HR. Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 1992; 20: 89–95
   PubMed Web of Science ®Google Scholar
• Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, et al. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993; 43: 354–8
   PubMed Web of Science ®Google Scholar
• Ohta K, Hirata Y, Shichiri M, Kanno K, Emon T, Tomita K, et al. Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 1991; 39: 307–11
   PubMed Web of Science ®Google Scholar
• Lee YJ, Shin SJ, Tsai JH. Increased uhary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 1994; 17: 263–6
   PubMed Web of Science ®Google Scholar
• Fukui M, Nakamura T, Ebihara I, Osada S, Tomino Y, Masaki T, et al. Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 1993; 122: 149–56
   PubMedGoogle Scholar
• Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H. Effect of a specific endothelin receptor antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes 1995; 44: 895–9
   PubMed Web of Science ®Google Scholar
• Shin SJ, Lee YJ, Hsiao PJ, Lin L, Wang SF, Chang FT, et al. The variability of 24-h, overnight 12-hour, and morning one-hour, urinary albumin excretion in normoalbuminuric and microalbuminuric hospitalized diabetics. Kaohsiung J Med Sci 1990; 6: 511–16
   Google Scholar
• Piatti P, Monti LD, Conti M, Baruffaldi L, Galli L, Phan CV, et al. Hypertriglyceridaemia and hyperinsulinaemia are potent inducers of endothelin-1 release in humans. Diabetes 1996; 45: 316–21
   PubMed Web of Science ®Google Scholar
• Ferri C, Bellini C, Desideri G, Di Francesco L, Baldoncini R, Santucci A, et al. Plasma endathelin-1 levels in obese hypertensive and normotensive men. Diabetes 1995; 44: 431–6
   PubMed Web of Science ®Google Scholar
• Widimsky J, Jr, Horky K, Dvorakova J. Plasma endothelin-1,2 levels in mild and severe hypertension. J Hypertens 1991; S194–5
   Google Scholar
• Chang CJ, Kao JT, Wu TJ, Lu FH, Tai TY. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients: relation to metabolic control. Diabetes Care 1995; 18: 1191–14
   PubMedGoogle Scholar
• Tai TY, Chuang LM, Wu HP, Chen CJ. Association of body build with non-insulindependent diabetes mellitus and hypertension among Chinese adults: a 4-year follow-up study. Int J Epidemiol 1992; 21: 511–17
   PubMedGoogle Scholar
• Simonson MS, Jones JM, Dunn MJ. Cytosolic and nuclear signaling by endothelin peptides: implications for the mesangial response to glomerular injury. Kidney Int 1992; 41: 542–5
   PubMed Web of Science ®Google Scholar
• Zoja C, Orisio S, Perico N, Benigni A, Morigi M, Benatti L, et al. Constitutive expression of endothelin gene in cultured human mesangial cells and its modulation by transforming growth factor-β, thrombin, and thromboxane A, analogue. Lab Invest 1991; 64: 16–20
   PubMed Web of Science ®Google Scholar
• Suzuki S. Effects of growth factors on the gene expression of extracellular matrix components in culltured rat rnesangial cells. Jpn J Nephrol 1993; 35: 97–104
   Google Scholar